Jun 29 |
Can Xilio Therapeutics (NASDAQ:XLO) Afford To Invest In Growth?
|
Jun 13 |
Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
|
May 29 |
Gilead and Cartography enter deal to develop cancer therapies
|
May 14 |
Xilio Therapeutics GAAP EPS of -$0.62
|
May 14 |
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
|
Apr 16 |
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
|
Apr 1 |
Xilio Therapeutics reports Q4 results
|
Apr 1 |
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
|
Apr 1 |
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
|
Mar 28 |
Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 Results
|